207 related articles for article (PubMed ID: 30718461)
1. Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3.
Hu X; Meng Y; Xu L; Qiu L; Wei M; Su D; Qi X; Wang Z; Yang S; Liu C; Han J
Cell Death Dis; 2019 Feb; 10(2):104. PubMed ID: 30718461
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer.
Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY
J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
4. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
Jeon YK; Kim CK; Koh J; Chung DH; Ha GH
Oncotarget; 2016 Jul; 7(27):41811-41824. PubMed ID: 27248820
[TBL] [Abstract][Full Text] [Related]
5. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract][Full Text] [Related]
6. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB
Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114
[TBL] [Abstract][Full Text] [Related]
7. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
Bradley A; Zheng H; Ziebarth A; Sakati W; Branham-O'Connor M; Blumer JB; Liu Y; Kistner-Griffin E; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Landen CN; Eblen ST
Carcinogenesis; 2014 May; 35(5):1100-9. PubMed ID: 24379240
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.
Liu C; Chen Z; Ding X; Qiao Y; Li B
Lab Invest; 2022 May; 102(5):524-533. PubMed ID: 35022505
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract][Full Text] [Related]
11. CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma.
Li T; Wu S; Jia L; Cao W; Yao Y; Zhao G; Li H
Cancer Biol Med; 2020 May; 17(2):357-370. PubMed ID: 32587774
[No Abstract] [Full Text] [Related]
12. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
Lu W; Yang C; He H; Liu H
Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
[TBL] [Abstract][Full Text] [Related]
13. TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Piro G; Giacopuzzi S; Bencivenga M; Carbone C; Verlato G; Frizziero M; Zanotto M; Mina MM; Merz V; Santoro R; Zanoni A; De Manzoni G; Tortora G; Melisi D
Br J Cancer; 2015 Sep; 113(6):878-85. PubMed ID: 26291056
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the
Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
[TBL] [Abstract][Full Text] [Related]
16. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
Duan W; Liu X
Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
[TBL] [Abstract][Full Text] [Related]
17. Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.
Sharifi HJ; Furuya AK; Jellinger RM; Nekorchuk MD; de Noronha CM
J Virol; 2014 Jun; 88(12):6944-58. PubMed ID: 24719410
[TBL] [Abstract][Full Text] [Related]
18. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
19. RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG.
Zhang Z; Pan Y; Zhao Y; Ren M; Li Y; Lu G; He S
Exp Cell Res; 2023 Aug; 429(1):113644. PubMed ID: 37211186
[TBL] [Abstract][Full Text] [Related]
20. The CRL4
Mohamed WI; Schenk AD; Kempf G; Cavadini S; Basters A; Potenza A; Abdul Rahman W; Rabl J; Reichermeier K; Thomä NH
EMBO J; 2021 Nov; 40(22):e108008. PubMed ID: 34595758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
